PCI Biotech Holding ASA (PCIB)

16.89
+0.12(+0.72%)
  • Volume:
    65,526
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    16.18 - 16.98
  • Type:Equity
  • Market:Norway
  • ISIN:NO0010405640
  • S/N:35201010

PCIB Overview

Prev. Close
16.77
Day's Range
16.18-16.98
Revenue
7.43M
Open
16.98
52 wk Range
15.2-49.6
EPS
-2.4
Volume
65,526
Market Cap
630.44M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
94,163
P/E Ratio
-
Beta
1.97
1-Year Change
-65.53%
Shares Outstanding
37,326,390
Next Earnings Date
Nov. 17, 2021
What is your sentiment on PCI Biotech Holding ASA?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsBuyStrong BuyBuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell

PCI Biotech Holding ASA Company Profile

PCI Biotech Holding ASA Company Profile

Employees
15
Market
Norway

PCI Biotech Holding ASA is a Norway-based company engaged in the biotechnology sector. Its activities are focused on the commercialization of a patented photochemical drug delivery technology for use in the localized cancer treatment. The Company’s products are based on the Photochemical Internalization (PCI) technology for light-directed drug delivery, used to enhance the effect of drugs by targeted illumination of the diseased areas of the body. It focuses primarily on the drug candidate Amphinex, developed for treatment of head and neck cancer and bile duct cancer, as well as on the development of PCI for vaccination. As of December 31, 2011, it had a wholly owned subsidiary PCI Biotech AS and an affiliate PCIO Biotech Utibu, located in Iceland.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.